2022 - Alliance Foundation Trial-46 CHIO3 Trial: CHemotherapy Combined with Immune Checkpoint Inhibitor for Operable Stage 3A/B NonSmall Cell Lung Cancer

https://legacy.aischannel.com/eric-socs/2022-alliance-foundation-trial-46-chio3-trial-chemotherapy-combined-with-immune-checkpoint-inhibitor-for-operable-stage-3ab-nonsmall-cell-lung-cancer